Marijuana Stocks Continue to Boom as Summer Comes to an End
Marijuana Industry NewsUncategorized September 13, 2018
The summer of this year has been hailed as one of the most important summers for the cannabis industry since its began. With new investments in the cannabis space and the addition of alcohol distributors and producers getting involved in the weed industry, it seems as though now is... Read more
These Marijuana Companies Are Still Under the Radar
Marijuana Industry NewsUncategorized September 13, 2018
The cannabis market has been quite lucrative for some time now, but new additions to legal measures around the world and the changing public perception of cannabis have all contributed to a fast-paced market growth. As new companies continue to innovate, it seems as though cannabis is the market... Read more
Integrated Cannabis Company, Inc. (ICNAF) Develops THC-Infused Spray Product
Uncategorized September 13, 2018
Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (the “Company” or “Integrated Cannabis”), is pleased to announce the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in Colorado. Over the past ten months the Company has engaged and worked... Read more
InMed Pharmaceuticals Inc. (IMLFF) Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results
Uncategorized September 13, 2018
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today reported financial results for the three and twelve months ended June 30, 2018, which is... Read more
Emblem Corp. (EMMBF) launches Atmosphere, its first oral dose-metered spray
Uncategorized September 13, 2018
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today announced the launch of its first oral dose-metered spray, Emblem Atmosphere. Designed with patients’ needs in mind,... Read more
Organigram Holdings Inc. (OGRMF) invests in Hyasynth Biologicals Inc.
Uncategorized September 13, 2018
Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram“), a leading licensed producer of medical marijuana, is pleased to announce the closing of its strategic investment in convertible secured debentures (the “Debentures“), to be purchased in three tranches and valued in... Read more
Marijuana Stocks Continues to Benefit the Little Guys
Marijuana Industry NewsUncategorized August 31, 2018
The cannabis market has managed to continue to boom for some time now, and the smaller stocks in the industry are also benefitting from the correlation between the market. As new innovation continues to hit the space, more and more investors are becoming comfortable with the idea of investing... Read more
Beleave Inc. (BLEVF) Secures Prime Location for its First Saskatchewan Retail Store
Uncategorized August 31, 2018
Beleave Inc. (BE.CN) (BLEVF) (“Beleave” or the “Company“) is excited to announce that it has secured a prime location for its first Saskatchewan retail store in the city of Lloydminster . Lloydminster has the unusual geographic distinction of straddling the provincial border with neighbouring Alberta . The city is... Read more
The Big Guys in the Cannabis Space Continue to Innovate
Marijuana Industry NewsUncategorized August 31, 2018
The cannabis space as a whole has been one of the most innovative spaces over the course of the past several years, but new updates to legislation and the changing public perception of cannabis have all contributed to the market drastically changing in the short term. Many of the... Read more
InMed Pharmaceuticals Inc. (IMLFF) to Present at the H.C. Wainwright 20th Annual Global Investment Conference
Uncategorized August 31, 2018
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that Josh Blacher , Chief Business Officer of InMed, will... Read more
